NCT04279119 - Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Adolescents and Adults With Chronic Plaque Psoriasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 10, 2020

Primary Completion Date

March 25, 2021

Study Completion Date

March 25, 2021

Conditions

Plaque Psoriasis

Interventions

DRUG

ARQ-151- cream 0.3%

ARQ-151 cream 0.3% applied to chronic plaque psoriasis lesions once a day for 2 weeks

Trial Locations (12)

Arcutis Clinical Site 08, Richmond

Arcutis Clinical Site 04, Sanford

Arcutis Clinical Site 06, Hialeah

Arcutis Clinical Site 03, Doral

Arcutis Clinical Site 07, Coral Gables

Arcutis Clinical Site 12, Miami

Arcutis Clinical Site 01, Dublin

Arcutis Clinical Site 02, Plainfield

Arcutis Clinical Site 09, Rogers

Arcutis Clinical Site 10, Arlington

Arcutis Clinical Site 05, San Antonio

Arcutis Clinical Site 11, Fountain Valley